MedPath

Medium-term Health Coaching and Life-long Monitoring in Diabetes Mellitus

Not Applicable
Completed
Conditions
Diabetes Mellitus Type 2
Interventions
Other: Self-monitoring for patients with Diabetes mellitus type 2
Other: Nurse-monitoring for patients with Diabetes mellitus type 2
Registration Number
NCT01580098
Lead Sponsor
Landeskrankenanstalten-Betriebsgesellschaft
Brief Summary

Evaluation whether the introduction of large-scale personalized and technology supported telemonitoring and health coaching interventions produces benefits in terms of health related quality of life, health status and empowerment of patients with type 2 diabetes mellitus. In addition, the trials evaluate the economical and organizational impact of the new services and examine their acceptability by patients and health professionals.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
193
Inclusion Criteria
  • T2DM diagnosed > 3 months prior to the enrollment
  • HbA1c >= 6,5 %
  • Capability of filling questionnaires by their own language
  • Being able to use the devices provided
  • Being cognitively able to participate
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Self-monitoring for patients with Diabetes mellitus type 2Self-monitoring for patients with Diabetes mellitus type 2Patients are self-monitoring and submitting their vital parameters.
Nurse-monitoring for patients with Diabetes mellitus type 2Nurse-monitoring for patients with Diabetes mellitus type 2Nurses are measuring and entering the vital parameters of the patients.
Primary Outcome Measures
NameTimeMethod
Health Related Quality of Life as Measured by the Short Form 36 Version 2 Questionnaire12 months

The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. The SF-36 is a measure of health status.

Mearurement at the beginning and after 12 months, Scales from 0 to 100, higher values represent a better outcome; Data are mean scores (SD); differences between groups after 12 month were compared by using Mann-Whitney-U-tests.

HbA1c12 months

HbA1c was taken at the beginning of the study and after 12 months.

Secondary Outcome Measures
NameTimeMethod
Blood Pressure12 months
Blood Lipids12 months
Body Weight12 months
Medication Changes12 months

Insulin, Change? -\> Yes/No

Presence of Diabetic Complications12 months
Number of Hospitalisations12 months

The number of inpatient stays comparing intervention and control group was conducted.

Trial Locations

Locations (3)

LKH Villach

🇦🇹

Villach, Carinthia, Austria

Klinikum Klagenfurt

🇦🇹

Klagenfurt, Carinthia, Austria

LKH Laas

🇦🇹

Kötschach, Carinthia, Austria

© Copyright 2025. All Rights Reserved by MedPath